Trial Profile
Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2023
Price :
$35
*
At a glance
- Drugs Omega-3-fatty-acid (Primary)
- Indications Hypertriglyceridaemia
- Focus Pharmacodynamics
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned initiation date changed from 1 Mar 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.